75061
Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate
≥95.0% (CHN)
동의어(들):
DOTA-tri-t-Bu-ester
로그인조직 및 계약 가격 보기
모든 사진(1)
크기 선택
보기 변경
100 MG
₩194,373
About This Item
실험식(Hill 표기법):
C28H52N4O8
CAS Number:
Molecular Weight:
572.73
MDL number:
UNSPSC 코드:
12352108
PubChem Substance ID:
NACRES:
NA.22
양식:
lumps
분석:
≥95.0% (CHN)
추천 제품
Quality Level
분석
≥95.0% (CHN)
양식
lumps
작용기
carboxylic acid
ester
SMILES string
CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(O)=O
InChI
1S/C28H52N4O8/c1-26(2,3)38-23(35)19-30-12-10-29(18-22(33)34)11-13-31(20-24(36)39-27(4,5)6)15-17-32(16-14-30)21-25(37)40-28(7,8)9/h10-21H2,1-9H3,(H,33,34)
InChI key
RVUXZXMKYMSWOM-UHFFFAOYSA-N
관련 카테고리
애플리케이션
Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (tri BOC-DOTA) can be employed as a reactant to prepare:
- Gadolinium ion functionalized with DOTA-LAE (lactobionic acid-ethylenediamine), which is used as a contrast agent for magnetic resonance imaging (MRI).[1]
- DOTA-conjugates of ursolic acid and ZD2 peptide 64Cu-DOTA conjugates.[2][3]
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
dust mask type N95 (US), Eyeshields, Gloves
이미 열람한 고객
Benjamin Poret et al.
Biomolecules, 10(3) (2020-03-25)
Overexpression of G protein-coupled receptors (GPCRs) in tumours is widely used to develop GPCR-targeting radioligands for solid tumour imaging in the context of diagnosis and even treatment. The human vasoactive neuropeptide urotensin II (hUII), which shares structural analogies with somatostatin
Synthesis and cytotoxicity evaluation of DOTA-conjugates of ursolic acid
Kahnt, M, et al.
Molecules (Basel), 24(12), 2254-2254 (2019)
Preparation and evaluation of ZD2 peptide 64Cu-DOTA conjugate as a positron emission tomography probe for detection and characterization of prostate cancer
Han Z, et al.
ACS Omega, 4(1), 1185-1190 (2019)
Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
Jeong Y and Na K
Biomaterials research, 22(1), 17-17 (2018)
Lubinda Mbundi et al.
Nanomaterials (Basel, Switzerland), 8(6) (2018-06-06)
The control of osteoblast/osteoclast cross-talk is crucial in the bone remodelling process and provides a target mechanism in the development of drugs for bone metabolic diseases. Osteoprotegerin is a key molecule in this biosignalling pathway as it inhibits osteoclastogenesis and
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.
